Network origin in Eric Harlé first degree
Entity | Entity type | Industry | |
---|---|---|---|
Sofimac Innovation SAS
Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector.
11
| Subsidiary | Investment Managers | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Eric Harlé via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALTRAN TECHNOLOGIES | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SEQUANS COMMUNICATIONS S.A. | Semiconductors | Director/Board Member | |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
TIGENIX NV | Medical Specialties | Director/Board Member | |
KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Turenne Capital Partenaires SA
Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Ventech SA
Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US. | Investment Managers | Private Equity Investor | |
Axone SA
Axone SA Medical/Nursing ServicesHealth Services Axone SA provides health care services. The company was founded in 2010 and is located in Genas, France | Medical/Nursing Services | Chief Executive Officer | |
SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Streamezzo SA
Streamezzo SA Information Technology ServicesTechnology Services Streamezzo SA develops software solutions for mobile phone. It develops platforms, that enable multimedia application deployment. The company was founded by Jean-Claude Dufourd, Cédric Gégout, and Olivier Avaro on February 4, 2004 and is headquartered in Rennes, France. | Information Technology Services | Director/Board Member | |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member | |
École Centrale Paris | College/University | Undergraduate Degree Undergraduate Degree | |
Télécom Paris | College/University | Graduate Degree | |
École Normale Supérieure | College/University | Undergraduate Degree | |
Ecole Nationale Supérieure de Techniques Avancées | College/University | Graduate Degree | |
Université Claude Bernard Lyon 1 | College/University | Doctorate Degree | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member | |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
SILKAN RT | Information Technology Services | Director of Finance/CFO | |
JeChange.fr SAS
JeChange.fr SAS Miscellaneous Commercial ServicesCommercial Services JeChange.fr SAS operates as a portal which offers online comparison service for comparing prices on a range of services including telecoms, insurance, credit and energy. The company was founded by Gaël Duval and Renaud Beaupère in 2007 and is headquartered in Estillac, Paris. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Eye Tech Care SA
Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France. | Medical Specialties | Director/Board Member | |
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
ImmunID SAS
ImmunID SAS Medical SpecialtiesHealth Technology ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member | |
CERADROP SA
CERADROP SA Industrial MachineryProducer Manufacturing CERADROP SA specializes in equipment for printed electronics. It designs and markets materials deposition digital printers exclusively for printed electronics industry and smart 3D printing. The firm provides ink formulation, equipment maintenance and support, and process development services. The company was founded in 2006 and is headquartered in Limoges, France. | Industrial Machinery | Director/Board Member | |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Director/Board Member | |
Cyanide SA
Cyanide SA Information Technology ServicesTechnology Services Cyanide SA develops video games. It offers sport, fantasy, and role plaing game which include Blood Bowl, Game of Thrones and Of Orcs. The company was founded by Patrick Pligersdorffer in 2000 and is headquartered in Nanterre, France. | Information Technology Services | Director/Board Member Director/Board Member | |
LeddarTech, Inc.
LeddarTech, Inc. Packaged SoftwareTechnology Services LeddarTech, Inc. develops and markets 3D detection and tracking systems. The firm?s solutions include auto and mobility LiDAR platform, mobility LiDAR and Specialty LiDAR modules, Sensor fusion and perception. It also offers its applications for passenger cars, autonomous shuttles, robotaxi, commercial and delivery vehicles. The company was founded by Yvan Mimeault, David Gilbert and Marc Tremblay in 2007 and is headquartered in Quebec, Canada. | Packaged Software | Director/Board Member Director/Board Member | |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Compario SA
Compario SA Internet Software/ServicesTechnology Services Compario SA provides e-marketing and merchandising solutions. Its services include consulting, training, project monitoring, and support and documentation. The company was founded by Frédéric Denel, Nicolas Sede and Romuald Poirot in 2004 and is headquartered in Paris, France. | Internet Software/Services | Director/Board Member | |
Captaindash SA
Captaindash SA Miscellaneous Commercial ServicesCommercial Services Captaindash SA provides advertising and market research services. It offers data management and advertising for real-time management. The company was founded by Gilles Babinet and Bruno Walther on November 2, 2009 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Finbiomed SARL | Chief Executive Officer | ||
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Director/Board Member | |
VALBIOTIS | Biotechnology | Director/Board Member | |
Physio-Assist SAS
Physio-Assist SAS Medical SpecialtiesHealth Technology Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France. | Medical Specialties | Director/Board Member |
Statistics
International
France | 38 |
United States | 5 |
Belgium | 3 |
United Kingdom | 3 |
Switzerland | 3 |
Sectoral
Health Technology | 21 |
Technology Services | 9 |
Commercial Services | 7 |
Consumer Services | 7 |
Electronic Technology | 4 |
Operational
Director/Board Member | 56 |
Private Equity Investor | 14 |
Undergraduate Degree | 5 |
Corporate Officer/Principal | 4 |
President | 4 |
Most connected contacts
- Stock Market
- Insiders
- Eric Harlé
- Company connections